Meravo 22,5 mg Injektionsvätska, lösning i förfylld injektionspenna

Country: Sweden

Language: Swedish

Source: Läkemedelsverket (Medical Products Agency)

Active ingredient:

metotrexat

Available from:

Alfrapharma s.r.l.

ATC code:

L04AX03

INN (International Name):

methotrexate

Dosage:

22,5 mg

Pharmaceutical form:

Injektionsvätska, lösning i förfylld injektionspenna

Composition:

metotrexat 22,5 mg Aktiv substans

Prescription type:

Receptbelagt

Product summary:

Förpacknings: Förfylld spruta, 2 st (22.5 mg/0,45 ml); Förfylld spruta, 4 st (22.5 mg/0,45 ml); Förfylld spruta, 5 st (22.5 mg/0,45 ml); Förfylld spruta, 6 st (22.5 mg/0,45 ml); Förfylld spruta, 10 st (22.5 mg/0,45 ml); Förfylld spruta, 12 st (22.5 mg/0,45 ml); Förfylld spruta, 1 st (22.5 mg/0,45 ml); Förfylld spruta, 14 st (22.5 mg/0,45 ml); Förfylld spruta, 15 st (22.5 mg/0,45 ml); Förfylld spruta, 24 st (22.5 mg/0,45 ml); Förfylld spruta, 11 st (22.5 mg/0,45 ml)

Authorization status:

Avregistrerad

Authorization date:

2019-08-16

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
MERAVO 7.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO10 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO 12.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO 15 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO 17.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO 20 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO 22.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
MERAVO 25 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
methotrexate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Meravo is and what it is used for
2.
What you need to know before you use Meravo
3.
How to use Meravo
4.
Possible side effects
5.
How to store Meravo
6.
Contents of the pack and other information
1.
WHAT MERAVO IS AND WHAT IT IS USED FOR
Meravo is indicated for the treatment of:

active rheumatoid arthritis in adult patients.

polyarthritic forms of severe, active juvenile idiopathic arthritis,
when the response to
nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.

moderate to severe psoriasis in adult patients, and severe psoriatic
arthritis in adults.

mild to moderate Crohn’s disease in adult patients when adequate
treatment with other
medicines is not possible.
RHEUMATOID ARTHRITIS
(RA) is a chronic disease, characterised by inflammation of the
synovial
membranes (joint membranes). These membranes produce a fluid which
acts as a lubricant for many
joints. The inflammation causes thickening of the membrane and
swelling of th

Summary of Product characteristics

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_